Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124332623 | 12433262 | 3 | F | 20160622 | 20160603 | 20160815 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-32129BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 90.26000 | KG | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124332623 | 12433262 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG | 654750 | 21698 | 150 | MG | TABLET | QD | |||||
| 124332623 | 12433262 | 2 | C | Acebuteollol | 2 | Oral | 400 MG | 0 | 400 | MG | TABLET | QD | |||||||
| 124332623 | 12433262 | 3 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG | 0 | 20 | MG | QD | |||||||
| 124332623 | 12433262 | 4 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 50 MG | 0 | 25 | MG | TABLET | BID | ||||||
| 124332623 | 12433262 | 5 | C | ARIMIDEX | ANASTROZOLE | 1 | Oral | 1 MG | 0 | 1 | MG | QD | |||||||
| 124332623 | 12433262 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | TABLET | QD | ||||||
| 124332623 | 12433262 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 75 MG | 0 | 75 | MG | TABLET | QD | ||||||
| 124332623 | 12433262 | 8 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Oral | 1500 MG | 0 | 500 | MG | TABLET | TID | ||||||
| 124332623 | 12433262 | 9 | C | Caltrate 600 D | 2 | Oral | 0 | TABLET | BID | ||||||||||
| 124332623 | 12433262 | 10 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124332623 | 12433262 | 1 | Dyspepsia |
| 124332623 | 12433262 | 2 | Hypertension |
| 124332623 | 12433262 | 3 | Fluid retention |
| 124332623 | 12433262 | 4 | Hypertension |
| 124332623 | 12433262 | 5 | Neoplasm malignant |
| 124332623 | 12433262 | 6 | Cardiovascular event prophylaxis |
| 124332623 | 12433262 | 7 | Thyroid disorder |
| 124332623 | 12433262 | 8 | Arthritis |
| 124332623 | 12433262 | 9 | Bone disorder |
| 124332623 | 12433262 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124332623 | 12433262 | Dyspepsia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124332623 | 12433262 | 1 | 20160511 | 0 |